213 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TMO Thermo Fisher Scientific Inc $238.46 $96.05B N/A
Article Searches
7 Dividend Growth Stocks to Buy for October http://www.zacks.com/stock/news/544089/7-dividend-growth-stocks-to-buy-for-october?cid=CS-ZC-FT-analyst_blog|rw-544089 Oct 01, 2019 - Dividend-paying securities are a major source of consistent income for investors when returns from the equity market are at risk.
Company News For Oct 24, 2019 http://www.zacks.com/stock/news/581965/company-news-for-oct-24-2019?cid=CS-ZC--corporate_summary-581965 Oct 24, 2019 - Companies In The News Are: ALXN,ANTM,TMO,BSX
GNC Holdings (GNC) Q3 Loss Meets Estimates, Revenues Miss http://www.zacks.com/stock/news/584233/gnc-holdings-gnc-q3-loss-meets-estimates-revenues-miss?cid=CS-ZC-FT-analyst_blog|earnings_article-584233 Oct 25, 2019 - GNC Holdings' (GNC) third-quarter 2019 results, reflecting dismal performance across segments, disappoint investors.
Cerner (CERN) Earnings Beat Estimates in Q3, Improve Y/Y http://www.zacks.com/stock/news/584186/cerner-cern-earnings-beat-estimates-in-q3-improve-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-584186 Oct 25, 2019 - Cerner (CERN) Q3 results benefit from higher revenues, gains in Licensed software, Technology resale, Professional and Managed services units, and international revenue growth.
Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year? http://www.zacks.com/stock/news/590431/has-thermo-fisher-scientific-tmo-outpaced-other-medical-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-590431 Oct 29, 2019 - Is (TMO) Outperforming Other Medical Stocks This Year?
Stryker (SYK) Q3 Earnings Meet Estimates, Revenues Beat http://www.zacks.com/stock/news/592590/stryker-syk-q3-earnings-meet-estimates-revenues-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-592590 Oct 30, 2019 - Stryker's (SYK) Q3 earnings gain from higher revenues, solid segmental performance and strong organic growth across businesses benefit.
Masimo (MASI) Earnings Beat Estimates in Q3, View Raised http://www.zacks.com/stock/news/594844/masimo-masi-earnings-beat-estimates-in-q3-view-raised?cid=CS-ZC-FT-analyst_blog|earnings_article-594844 Oct 31, 2019 - Masimo (MASI) raises its 2019 product revenue guidance.
Amedisys (AMED) Q3 Earnings Beat Estimates, Revenues Meet http://www.zacks.com/stock/news/596670/amedisys-amed-q3-earnings-beat-estimates-revenues-meet?cid=CS-ZC-FT-analyst_blog|earnings_article-596670 Oct 31, 2019 - Amedisys (AMED) continues to witness solid year-over-year growth in Medicare and non-Medicare revenues within Home Health.
Impressive Near-Term Outlook for Medical Instruments Industry http://www.zacks.com/commentary/595185/impressive-near-term-outlook-for-medical-instruments-industry?cid=CS-ZC--industry_outlook-595185 Oct 31, 2019 - Impressive Near-Term Outlook for Medical Instruments Industry
NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q3 http://www.zacks.com/stock/news/597826/nuvasive-nuva-earnings-and-revenues-beat-estimates-in-q3?cid=CS-ZC-FT-analyst_blog|earnings_article-597826 Nov 01, 2019 - We are encouraged to note that NuVasive (NUVA) witnessed solid revenue growth across its U.S. Spinal Hardware business in Q3.

Pages: 1...89101112131415161718...22

<<<Page 13>